International Peptide Laws
Peptide regulations vary significantly worldwide. This guide provides an overview of peptide laws by country and region, covering legal status, regulatory bodies, and import/export considerations.
North America
🇺🇸 United States
RestrictedIn the United States, peptides are not a distinct legal category — they are regulated as drugs under the Federal Food, Drug, and Cosmetic Act. A handful of...
🇨🇦 Canada
RestrictedIn Canada, injectable peptides are regulated as prescription drugs under the Food and Drugs Act framework, and no 'research chemical' or wellness-marketed...
🇲🇽 Mexico
RestrictedMexico has no peptide-specific statute; peptides intended for human use are handled under the general medicines framework of the Ley General de Salud, which...
Europe
🇬🇧 United Kingdom
RestrictedPeptides are not treated as a single legal category in the UK; their status depends on the specific molecule and on how it is sold. Growth-hormone-type...
🇪🇺 European Union
RestrictedIn the European Union, peptides intended for human therapeutic use are regulated as medicinal products, not as a separate 'research chemical' category: no...
🇩🇪 Germany
RestrictedIn Germany there is no separate 'peptide law'; peptides are handled under general medicines law (Arzneimittelgesetz/AMG), the prescription regulation (AMVV)...
🇳🇱 Netherlands
RestrictedThe Netherlands has no peptide-specific statute; peptides are handled under the general Medicines Act (Geneesmiddelenwet), which means that any peptide...
🇫🇷 France
RestrictedIn France there is no separate legal category for "research peptides": any product presented or used for a therapeutic, weight-loss or performance purpose is...
🇪🇸 Spain
RestrictedSpain has no peptide-specific statute; peptides are handled under general EU/Spanish medicines law, which means any product presented for human therapeutic use...
🇮🇹 Italy
RestrictedItaly has no separate legal category for 'research peptides': any peptide with a pharmacological action is treated as a medicine, so it can only be lawfully...
🇵🇱 Poland
RestrictedPoland does not treat peptides as a distinct legal category: each compound is assessed under the Pharmaceutical Law of 6 September 2001. Peptides that are...
🇨🇠Switzerland
RestrictedIn Switzerland, peptides are not treated as a single legal category: peptide-based medicines (such as GLP-1 weight-loss drugs and hormone-type peptides) are...
Asia-Pacific
🇦🇺 Australia
RestrictedPeptides are not banned outright in Australia, but they are tightly controlled as medicines rather than as unregulated 'research chemicals'. Most therapeutic...
🇳🇿 New Zealand
RestrictedIn New Zealand, peptides are regulated as medicines under the Medicines Act 1981, administered by Medsafe, rather than as a separate 'research chemical'...
🇯🇵 Japan
RestrictedJapan has no peptide-specific statute or separate 'peptide schedule'; instead, peptides intended for human use (BPC-157, TB-500, semaglutide-class GLP-1 drugs,...
🇰🇷 South Korea
RestrictedPeptides in South Korea are handled entirely through pharmaceutical law rather than a separate 'peptide' or 'research chemical' category: any peptide intended...
🇨🇳 China
RestrictedPeptides are not an unregulated 'research chemical' category in China: peptide hormones are expressly captured by the State Council's Anti-Doping Regulations,...
🇮🇳 India
RestrictedIn India there is no separate 'peptide' category in law: therapeutic peptides are treated as drugs under the Drugs and Cosmetics Act, 1940 and Rules, 1945, and...
🇹🇠Thailand
RestrictedThailand does not have a peptide-specific law; instead, peptides are captured by the general medicines framework under the Drug Act B.E. 2510 (1967), which is...
🇸🇬 Singapore
RestrictedSingapore has no peptide-specific statute, but peptide drugs fall squarely within the general medicines framework: they are treated as therapeutic products...
Africa
🇿🇦 South Africa
RestrictedSouth Africa does not have a peptide-specific statute; instead, peptides are caught by the general medicines framework under the Medicines and Related...
South America
🇧🇷 Brazil
RestrictedIn Brazil, peptides are not treated as a single legal category: approved peptide medicines (such as GLP-1 agonists like semaglutide, liraglutide and...
🇦🇷 Argentina
RestrictedIn Argentina, peptides intended for human use are treated as medicines and fall under national medicines law, which requires prior government authorization for...
🇨🇴 Colombia
RestrictedIn Colombia there is no peptide-specific statute; peptides are handled under the general medicines regime, which means any product with a therapeutic claim...
Middle East
🇦🇪 UAE
RestrictedIn the UAE, peptides are treated as medicinal products rather than as a separate, unregulated category: any peptide sold or used therapeutically must be...
🇮🇱 Israel
RestrictedIsrael has no peptide-specific statute; peptides that are intended for human therapeutic use are treated as medicinal preparations under the Pharmacists...
🇸🇦 Saudi Arabia
RestrictedPeptides in Saudi Arabia are treated as pharmaceutical products rather than supplements or unregulated 'research chemicals': anything marketed, sold, imported...
International Import/Export Considerations
General Principles
- Customs declarations: Most countries require accurate customs declarations for pharmaceutical products
- Personal use exemptions: Some countries allow limited personal imports, others do not
- Documentation: Prescriptions or research documentation may facilitate customs clearance
- Prohibited substances: Some peptides may be classified as controlled substances in certain countries
High-Risk Jurisdictions
Countries with particularly strict enforcement include:
- Australia - strict TGA enforcement, significant import controls
- UAE - strict customs inspection, severe penalties
- Japan - extensive import documentation required
- Singapore - strict pharmaceutical controls
Regulatory Bodies by Region
- North America: FDA (US), Health Canada, COFEPRIS (Mexico)
- Europe: EMA (EU-wide), MHRA (UK), BfArM (Germany)
- Asia-Pacific: TGA (Australia), PMDA (Japan), NMPA (China)
- South America: ANVISA (Brazil), ANMAT (Argentina)